Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENG Block Dose Finding for Hip Fracture Analgesia
NCT05095025Unknown
- Sponsor
- University College Cork
- Start
- Sep 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Double-blind, single-arm trial of bupivacaine in acute pain, sponsored by University College Cork. Primary endpoint: Analgesic success at 30 minutes. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05095025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05095025.